Cargando…
Comment on ‘Evaluation of the Reported Rates of Severe Hypersensitivity Reactions Associated with Ferric Carboxymaltose and Iron(III) Isomaltoside 1000 in Europe Based on Data from EudraVigilance and VigiBase™ Between 2014 and 2017’
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475518/ https://www.ncbi.nlm.nih.gov/pubmed/30937852 http://dx.doi.org/10.1007/s40264-019-00814-5 |
| _version_ | 1783412761823281152 |
|---|---|
| author | Schaffalitzky de Muckadell, Philip Strom, Claes Christian |
| author_facet | Schaffalitzky de Muckadell, Philip Strom, Claes Christian |
| author_sort | Schaffalitzky de Muckadell, Philip |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6475518 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-64755182019-05-07 Comment on ‘Evaluation of the Reported Rates of Severe Hypersensitivity Reactions Associated with Ferric Carboxymaltose and Iron(III) Isomaltoside 1000 in Europe Based on Data from EudraVigilance and VigiBase™ Between 2014 and 2017’ Schaffalitzky de Muckadell, Philip Strom, Claes Christian Drug Saf Letter to the Editor Springer International Publishing 2019-04-01 2019 /pmc/articles/PMC6475518/ /pubmed/30937852 http://dx.doi.org/10.1007/s40264-019-00814-5 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
| spellingShingle | Letter to the Editor Schaffalitzky de Muckadell, Philip Strom, Claes Christian Comment on ‘Evaluation of the Reported Rates of Severe Hypersensitivity Reactions Associated with Ferric Carboxymaltose and Iron(III) Isomaltoside 1000 in Europe Based on Data from EudraVigilance and VigiBase™ Between 2014 and 2017’ |
| title | Comment on ‘Evaluation of the Reported Rates of Severe Hypersensitivity Reactions Associated with Ferric Carboxymaltose and Iron(III) Isomaltoside 1000 in Europe Based on Data from EudraVigilance and VigiBase™ Between 2014 and 2017’ |
| title_full | Comment on ‘Evaluation of the Reported Rates of Severe Hypersensitivity Reactions Associated with Ferric Carboxymaltose and Iron(III) Isomaltoside 1000 in Europe Based on Data from EudraVigilance and VigiBase™ Between 2014 and 2017’ |
| title_fullStr | Comment on ‘Evaluation of the Reported Rates of Severe Hypersensitivity Reactions Associated with Ferric Carboxymaltose and Iron(III) Isomaltoside 1000 in Europe Based on Data from EudraVigilance and VigiBase™ Between 2014 and 2017’ |
| title_full_unstemmed | Comment on ‘Evaluation of the Reported Rates of Severe Hypersensitivity Reactions Associated with Ferric Carboxymaltose and Iron(III) Isomaltoside 1000 in Europe Based on Data from EudraVigilance and VigiBase™ Between 2014 and 2017’ |
| title_short | Comment on ‘Evaluation of the Reported Rates of Severe Hypersensitivity Reactions Associated with Ferric Carboxymaltose and Iron(III) Isomaltoside 1000 in Europe Based on Data from EudraVigilance and VigiBase™ Between 2014 and 2017’ |
| title_sort | comment on ‘evaluation of the reported rates of severe hypersensitivity reactions associated with ferric carboxymaltose and iron(iii) isomaltoside 1000 in europe based on data from eudravigilance and vigibase™ between 2014 and 2017’ |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475518/ https://www.ncbi.nlm.nih.gov/pubmed/30937852 http://dx.doi.org/10.1007/s40264-019-00814-5 |
| work_keys_str_mv | AT schaffalitzkydemuckadellphilip commentonevaluationofthereportedratesofseverehypersensitivityreactionsassociatedwithferriccarboxymaltoseandironiiiisomaltoside1000ineuropebasedondatafromeudravigilanceandvigibasebetween2014and2017 AT stromclaeschristian commentonevaluationofthereportedratesofseverehypersensitivityreactionsassociatedwithferriccarboxymaltoseandironiiiisomaltoside1000ineuropebasedondatafromeudravigilanceandvigibasebetween2014and2017 |